Purpose. The performance of a weight-based dosing protocol for unfractionated heparin (UFH) infusions using antifactor Xa monitoring was evaluated. Methods. The first 50 patients to receive a UFH ...

This webinar will look at the principles of the assays available to monitor heparin. The most frequent assay that is used is the activated partial thromboplastin time (aPTT). This assay is readily ...

Venous thromboembolism (VTE) is common in patients with cancer. Long-term daily subcutaneous low molecular weight heparin has been standard treatment for such patients. The purpose of this study was ...

Ever since the introduction of the direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, laboratory staff and clinicians have been confronted with unique challenges in determining ...

An automated chromogenic test called the INNOVANCE Anti-Xa assay is used to quantify the levels of rivaroxaban 1, apixaban, and edoxaban 1 in citrated human plasma, as well as the activity of ...

Low molecular weight heparin (LMWH) is an anticoagulant injected subcutaneously or intravenously and acts via activation of antithrombin III which in turn inactivates thrombin and factor Xa to produce ...

A new study has shown that COVID-19 patients admitted to the Intensive care unit may be resistant to the naturally occurring anticoagulant Heparin. The study titled, “Heparin resistance in COVID‑19 ...

It is not clear whether individuals with severely impaired renal function are more susceptible to bleeding complications of low-molecular-weight heparin (LMWH). Published and unpublished studies in ...

Venous thromboembolism (VTE) is common in patients with cancer. Long-term daily subcutaneous low molecular weight heparin has been standard treatment for such patients. The purpose of this study was ...

Am J Health Syst Pharm. 2010;67(5):371-374. The true success of any heparin dosing protocol would not be the amount of infusion adjustments or time to achieve a target level but rather its ability to ...